108 related articles for article (PubMed ID: 31322832)
1. Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.
Usama SM; Jiang Z; Pflug K; Sitcheran R; Burgess K
ChemMedChem; 2019 Sep; 14(17):1575-1579. PubMed ID: 31322832
[TBL] [Abstract][Full Text] [Related]
2. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional heptamethine near-infrared dye for cancer theranosis.
Luo S; Tan X; Qi Q; Guo Q; Ran X; Zhang L; Zhang E; Liang Y; Weng L; Zheng H; Cheng T; Su Y; Shi C
Biomaterials; 2013 Mar; 34(9):2244-51. PubMed ID: 23261220
[TBL] [Abstract][Full Text] [Related]
4. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.
Kim YJ; Hong S; Sung M; Park MJ; Jung K; Noh KW; Oh DY; Lee MS; Oh E; Shin YK; Choi YL
Oncotarget; 2016 Dec; 7(50):82876-82888. PubMed ID: 27756880
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
Cooper E; Choi PJ; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; I-H Park T; Jose J
Bioorg Med Chem Lett; 2021 Oct; 50():128336. PubMed ID: 34438012
[TBL] [Abstract][Full Text] [Related]
6. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y
PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796
[TBL] [Abstract][Full Text] [Related]
7. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.
Jiang Z; Pflug K; Usama SM; Kuai D; Yan X; Sitcheran R; Burgess K
J Med Chem; 2019 Oct; 62(20):9236-9245. PubMed ID: 31469566
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
Cooper E; Oyagawa CRM; Johnson R; Choi PJ; Foliaki JM; Correia J; Schweder P; Heppner P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Jose J; Park TI
Cell Commun Signal; 2024 Jan; 22(1):30. PubMed ID: 38212807
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
McKnight BN; Viola-Villegas NT
Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.
Luo FR; Barrett YC; Yang Z; Camuso A; McGlinchey K; Wen ML; Smykla R; Fager K; Wild R; Palme H; Galbraith S; Blackwood-Chirchir A; Lee FY
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1065-74. PubMed ID: 18301894
[TBL] [Abstract][Full Text] [Related]
11. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
[TBL] [Abstract][Full Text] [Related]
12. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.
Choi PJ; Cooper E; Schweder P; Mee E; Faull R; Denny WA; Dragunow M; Park TI; Jose J
Bioorg Med Chem Lett; 2019 Sep; 29(18):2617-2621. PubMed ID: 31378572
[TBL] [Abstract][Full Text] [Related]
13. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
[TBL] [Abstract][Full Text] [Related]
14. Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy.
Duong T; Li X; Yang B; Schumann C; Albarqi HA; Taratula O; Taratula O
Nanomedicine; 2017 Apr; 13(3):955-963. PubMed ID: 27884637
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer.
Sun Y; Lin X; Aske JC; Ye P; Williams C; Abramovitz M; Leyland-Jones BR
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1241-1256. PubMed ID: 31541266
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.
Teng Y; Cai Y; Pi W; Gao L; Shay C
J Hematol Oncol; 2017 Jun; 10(1):118. PubMed ID: 28606127
[TBL] [Abstract][Full Text] [Related]
18. A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma.
Sun J; Wang X; Tang B; Liu H; Zhang M; Wang Y; Ping F; Ding J; Shen A; Geng M
Theranostics; 2018; 8(12):3256-3267. PubMed ID: 29930727
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling.
Levitt JM; Yamashita H; Jian W; Lerner SP; Sonpavde G
Mol Cancer Ther; 2010 May; 9(5):1128-35. PubMed ID: 20406945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
